{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:22:13Z","timestamp":1787318533691,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fonds National de la Recherche et de l\u2019Innovation pour le D\u00e9veloppement"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dengue fever (DF) is a significant public health concern in Burkina Faso, particularly in the Central Region, previously endemic for malaria. However, limited research has focused on dengue prevalence and associated factors among adult febrile patients in this region. This study aimed to estimate the prevalence of symptomatic dengue fever among adults and identify the sociodemographic and clinical determinants of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A seroepidemiological cross-sectional study was conducted in the Central Region of Burkina Faso, through a three-stage sampling. Five health facilities, one from each of the region five districts, were purposively selected. Febrile patients aged 16 and older, suspected of having dengue, were included in the study, after consenting. Bivariate analyses and multivariate binary logistic regression were done at a 5% confidence level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 637 patients between the ages of 16 and 90\u00a0years were included. Most of the participants were females (58.71%). Most dengue cases resided in Arrondissement 4 (59.62%), or were present in the Arrondissement\u00a04 at daytime during the previous days (51.92%). 52.90% of the participants knew of dengue. Dengue prevalence was estimated at 8.16% (95% CI: 6.16%-10.57%). The most frequent markers for dengue were immunoglobulins M detected in 4.40% (2.94%-6.29%), followed by Antigen NS1 at 4.24% (95% CI: 2.81%-6.11%). The Antigen NS1 marker was associated with myalgia (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), vomiting (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), hemorrhagic manifestations (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), and anorexia (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Staying at Arrondissement 4 (vs staying at Saaba) during daytime (aOR\u2009=\u20092.36 95% CI: 1.03\u20135.45;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044) significantly increased the odds of dengue. Dengue cases were about 3 times more likely to have vomited (aOR\u2009=\u20092.99 95% CI: 1.58\u20135.64;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Participants knowing of dengue (aOR\u2009=\u20090.53 95% CI: 0.29\u20130.98;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042) and those coinfected with malaria (aOR\u2009=\u20090.28 95% CI: 0.14\u20130.57;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) instead had reduced odds of dengue.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study revealed a relatively high prevalence of symptomatic dengue fever among adults in the Central Region of Burkina Faso in 2022. These findings emphasize the need for continuous surveillance and targeted control measures. The low coinfection of dengue and malaria warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08932-3","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T08:02:26Z","timestamp":1704182546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Determinants and prevalence of symptomatic dengue fever among adults in the Central Region of Burkina Faso: a hospital-based cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jean Claude Romaric Pingdwind\u00e9","family":"Ou\u00e9draogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Ilboudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tegwind\u00e9 Rebeca","family":"Compaor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper","family":"Bado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Niti\u00e9ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendlasida Thomas","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salfo","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadi","family":"Zeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Tougma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy Gueswind\u00e9","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noufou","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvin","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9on Gueswend\u00e9 Blaise","family":"Savadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"8932_CR1","unstructured":"WHO. Dengue and severe dengue [Internet]. World Health Organization. 2023 . Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue. [Cited 2023 Mar 29]."},{"key":"8932_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/v14020233","volume":"14","author":"EM Gainor","year":"2022","unstructured":"Gainor EM, Harris E, LaBeaud AD. Uncovering the burden of dengue in Africa: considerations on magnitude, misdiagnosis, and ancestry. Viruses. 2022;14:233","journal-title":"Viruses"},{"key":"8932_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504\u20137.","journal-title":"Nature"},{"key":"8932_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.actatropica.2014.02.017","volume":"134","author":"J Stoler","year":"2014","unstructured":"Stoler J, al Dashti R, Anto F, Fobil JN, Awandare GA. Deconstructing Malaria: West Africa as the next front for dengue fever surveillance and control. Acta Trop. 2014;134:58\u201365.","journal-title":"Acta Trop"},{"key":"8932_CR5","doi-asserted-by":"publisher","first-page":"13626","DOI":"10.1038\/s41598-019-50135-x","volume":"9","author":"FBN Simo","year":"2019","unstructured":"Simo FBN, Bigna JJ, Kenmoe S, Ndangang MS, Temfack E, Moundipa PF, et al. Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies. Sci Rep. 2019;9:13626.","journal-title":"Sci Rep"},{"key":"8932_CR6","first-page":"1349","volume":"17","author":"A Amarasinghe","year":"2011","unstructured":"Amarasinghe A. Dengue virus Infection in Africa. Emerg Infect Dis. 2011;17:1349\u201354.","journal-title":"Emerg Infect Dis"},{"key":"8932_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04389","volume":"6","author":"J Im","year":"2020","unstructured":"Im J, Balasubramanian R, Ouedraogo M, Wandji Nana LR, Mogeni OD, Jeon HJ, et al. The epidemiology of dengue outbreaks in 2016 and 2017 in Ouagadougou, Burkina Faso. Heliyon. 2020;6: e04389.","journal-title":"Heliyon"},{"key":"8932_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3201\/eid2401.170973","volume":"24","author":"Z Tarnagda","year":"2018","unstructured":"Tarnagda Z, Ciss\u00e9 A, Bicaba BW, Diagbouga S, Sagna T, Ilboudo AK, et al. Dengue fever in Burkina Faso, 2016. Emerg Infect Dis. 2018;24:170\u20132.","journal-title":"Emerg Infect Dis"},{"key":"8932_CR9","doi-asserted-by":"publisher","first-page":"e0007882","DOI":"10.1371\/journal.pntd.0007882","volume":"13","author":"JK Lim","year":"2019","unstructured":"Lim JK, Seydou Y, Carabali M, Barro A, Dahourou DL, Lee KS, et al. Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou, Burkina Faso. Plos Negl Trop Dis. 2019;13:e0007882.","journal-title":"Plos Negl Trop Dis"},{"key":"8932_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40249-016-0120-2","volume":"5","author":"V Ridde","year":"2016","unstructured":"Ridde V, Agier I, Bonnet E, Carabali M, Dabir\u00e9 KR, Fournet F, et al. Presence of three dengue serotypes in Ouagadougou (Burkina Faso): research and public health implications. Infect Dis Poverty. 2016;5:23.","journal-title":"Infect Dis Poverty"},{"key":"8932_CR11","first-page":"478","volume-title":"Annuaire statistique 2020","author":"Minist\u00e8re de la sant\u00e9","year":"2021","unstructured":"Minist\u00e8re de la sant\u00e9. Annuaire statistique 2020. Burkina Faso: DGESS: Ouagadougou; 2021. p. 478."},{"key":"8932_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/pathogens11070741","volume":"11","author":"B Tinto","year":"2022","unstructured":"Tinto B, Kabor\u00e9 DPA, Kania D, Kagon\u00e9 TS, Kiba-Koumar\u00e9 A, Pinceloup L, et al. Serological evidence of Zika Virus circulation in Burkina Faso. Pathogens. 2022;11:741.","journal-title":"Pathogens"},{"key":"8932_CR13","doi-asserted-by":"publisher","first-page":"205031211879458","DOI":"10.1177\/2050312118794589","volume":"6","author":"S Zongo","year":"2018","unstructured":"Zongo S, Carabali M, Munoz M, Ridde V. Dengue rapid diagnostic tests: health professionals\u2019 practices and challenges in Burkina Faso. SAGE Open Medicine. 2018;6:205031211879458.","journal-title":"SAGE Open Medicine"},{"key":"8932_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12879-015-1058-x","volume":"15","author":"M Carabali","year":"2015","unstructured":"Carabali M, Hernandez LM, Arauz MJ, Villar LA, Ridde V. Why are people with dengue dying? A scoping review of determinants for dengue mortality. BMC Infect Dis. 2015;15:301.","journal-title":"BMC Infect Dis"},{"key":"8932_CR15","unstructured":"Direction R\u00e9gionale de la Sant\u00e9 du Centre. Plan d\u2019Action 2022. Burkina Faso: Minist\u00e8re de la sant\u00e9 et de l\u2019hygi\u00e8ne publique; 2022."},{"key":"8932_CR16","first-page":"76","volume-title":"Cinqui\u00e8me recensement g\u00e9n\u00e9ral de la population et de l\u2019habitation du Burkina Faso. R\u00e9sultats pr\u00e9liminaires","author":"INSD","year":"2020","unstructured":"INSD. Cinqui\u00e8me recensement g\u00e9n\u00e9ral de la population et de l\u2019habitation du Burkina Faso. R\u00e9sultats pr\u00e9liminaires. Ouagadougou, Burkina Faso: Minist\u00e8re de l\u2019Economie, des Finances et du D\u00e9veloppement; 2020. p. 76."},{"key":"8932_CR17","unstructured":"Programme national de lutte contre les maladies tropicales n\u00e9glig\u00e9es. Directives nationales de prise en charge des cas de dengue Au Burkina Faso. Burkina Faso: Minist\u00e8re de la sant\u00e9 et de l\u2019hygi\u00e8ne publique; 2023."},{"key":"8932_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","volume":"35","author":"J Charan","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in Medical Research? Indian J Psychol Med. 2013;35:121\u20136.","journal-title":"Indian J Psychol Med"},{"key":"8932_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4314\/ajcem.v23i4.8","volume":"23","author":"SOT Bello","year":"2022","unstructured":"Bello SOT, Houkpevi A, Zackari S, Tapsoba ASA, Zoure AA, Ilboudo PD, et al. Epidemiology of Dengue in patients with febrile syndrome at Saint Camille Hospital, Ouagadougou, Burkina Faso from 2020 to 2021. Af J Clin Exp Micro. 2022;23:398\u2013406.","journal-title":"Af J Clin Exp Micro"},{"key":"8932_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12889-022-12820-x","volume":"22","author":"CA Ouattara","year":"2022","unstructured":"Ouattara CA, Traore S, Sangare I, Traore TI, Meda ZC, Savadogo LGB. Spatiotemporal analysis of dengue Fever in Burkina Faso from 2016 to 2019. BMC Public Health. 2022;22:462.","journal-title":"BMC Public Health"},{"key":"8932_CR21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3201\/eid2410.180069","volume":"24","author":"S Ou\u00e9draogo","year":"2018","unstructured":"Ou\u00e9draogo S, Benmarhnia T, Bonnet E, Som\u00e9 P-A, Barro AS, Kafando Y, et al. Evaluation of effectiveness of a community-based intervention for control of dengue virus vector, Ouagadougou, Burkina Faso. Emerg Infect Dis. 2018;24:1859\u201367.","journal-title":"Emerg Infect Dis"},{"key":"8932_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41256-018-0078-7","volume":"3","author":"D Sar\u00e9","year":"2018","unstructured":"Sar\u00e9 D, P\u00e9rez D, Som\u00e9 P-A, Kafando Y, Barro A, Ridde V. Community-based dengue control intervention in Ouagadougou: intervention theory and implementation fidelity. Global Health Research and Policy. 2018;3:21.","journal-title":"Global Health Research and Policy"},{"key":"8932_CR23","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12889-019-7488-4","volume":"19","author":"M Kotepui","year":"2019","unstructured":"Kotepui M, Kotepui KU. Prevalence and laboratory analysis of Malaria and dengue co-infection: a systematic review and meta-analysis. BMC Public Health. 2019;19:1148.","journal-title":"BMC Public Health"},{"key":"8932_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/jmv.24788","volume":"89","author":"OM Kolawole","year":"2017","unstructured":"Kolawole OM, Seriki AA, Irekeola AA, Bello KE, Adeyemi OO. Dengue virus and Malaria concurrent infection among febrile subjects within Ilorin metropolis, Nigeria. J Med Virol. 2017;89:1347\u201353.","journal-title":"J Med Virol"},{"key":"8932_CR25","doi-asserted-by":"publisher","first-page":"115116","DOI":"10.1016\/j.diagmicrobio.2020.115116","volume":"98","author":"MS Santoso","year":"2020","unstructured":"Santoso MS, Yohan B, Denis D, Hayati RF, Haryanto S, Trianty L, et al. Diagnostic accuracy of 5 different brands of dengue virus non-structural protein 1 (NS1) antigen rapid diagnostic tests (RDT) in Indonesia. Diagn Microbiol Infect Dis. 2020;98:115116.","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08932-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08932-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08932-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T08:03:44Z","timestamp":1704182624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08932-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8932"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08932-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional Ethics Committee (CEIRES) from the Institut de Recherche en Sciences de la Sant\u00e9 (IRSS) [number 032\u20132022\/CEIRES] and the national Ethics Committee (CERS) [N\u00b0 2022\u201312-257] approved the study.The study was conducted according to the Declaration of Helsinki. Signed informed consent was obtained from each participant after the study objectives and processes were explained. Assent was also obtained from the participants 16 to 18\u00a0years old, along with the parent or caregiver\u2019s informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}